These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 18709645)

  • 21. N-myc downstream-regulated gene 2 (NDRG2) promoter methylation and expression in pituitary adenoma.
    Vaitkiene P; Valiulyte I; Glebauskiene B; Liutkeviciene R
    Diagn Pathol; 2017 Apr; 12(1):33. PubMed ID: 28390436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Promoter hypermethylation-mediated down-regulation of CXCL12 in human astrocytoma.
    Zhou W; Jiang Z; Song X; Liu Y; Wen P; Guo Y; Xu F; Kong L; Zhang P; Han A; Yu J
    J Neurosci Res; 2008 Oct; 86(13):3002-10. PubMed ID: 18512766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutational profile of the PTEN gene in primary human astrocytic tumors and cultivated xenografts.
    Schmidt EE; Ichimura K; Goike HM; Moshref A; Liu L; Collins VP
    J Neuropathol Exp Neurol; 1999 Nov; 58(11):1170-83. PubMed ID: 10560660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IDH1 mutations is prognostic marker for primary glioblastoma multiforme but MGMT hypermethylation is not prognostic for primary glioblastoma multiforme.
    Kalkan R; Atli Eİ; Özdemir M; Çiftçi E; Aydin HE; Artan S; Arslantaş A
    Gene; 2015 Jan; 554(1):81-6. PubMed ID: 25455102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monosomy of chromosome 10 associated with dysregulation of epidermal growth factor signaling in glioblastomas.
    Yadav AK; Renfrow JJ; Scholtens DM; Xie H; Duran GE; Bredel C; Vogel H; Chandler JP; Chakravarti A; Robe PA; Das S; Scheck AC; Kessler JA; Soares MB; Sikic BI; Harsh GR; Bredel M
    JAMA; 2009 Jul; 302(3):276-89. PubMed ID: 19602687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NDRG2 is a candidate tumor-suppressor for oral squamous-cell carcinoma.
    Furuta H; Kondo Y; Nakahata S; Hamasaki M; Sakoda S; Morishita K
    Biochem Biophys Res Commun; 2010 Jan; 391(4):1785-91. PubMed ID: 20045673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA hypermethylation and aberrant expression of the EMP3 gene at 19q13.3 in Human Gliomas.
    Kunitz A; Wolter M; van den Boom J; Felsberg J; Tews B; Hahn M; Benner A; Sabel M; Lichter P; Reifenberger G; von Deimling A; Hartmann C
    Brain Pathol; 2007 Oct; 17(4):363-70. PubMed ID: 17610521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic silencing of NDRG2 promotes colorectal cancer proliferation and invasion.
    Hong SN; Kim SJ; Kim ER; Chang DK; Kim YH
    J Gastroenterol Hepatol; 2016 Jan; 31(1):164-71. PubMed ID: 26250123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional and clinical evidence for NDRG2 as a candidate suppressor of liver cancer metastasis.
    Lee DC; Kang YK; Kim WH; Jang YJ; Kim DJ; Park IY; Sohn BH; Sohn HA; Lee HG; Lim JS; Kim JW; Song EY; Kim DM; Lee MN; Oh GT; Kim SJ; Park KC; Yoo HS; Choi JY; Yeom YI
    Cancer Res; 2008 Jun; 68(11):4210-20. PubMed ID: 18519680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MGMT activity, promoter methylation and immunohistochemistry of pretreatment and recurrent malignant gliomas: a comparative study on astrocytoma and glioblastoma.
    Christmann M; Nagel G; Horn S; Krahn U; Wiewrodt D; Sommer C; Kaina B
    Int J Cancer; 2010 Nov; 127(9):2106-18. PubMed ID: 20131314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glioma Malignancy-Dependent NDRG2 Gene Methylation and Downregulation Correlates with Poor Patient Outcome.
    Skiriutė D; Steponaitis G; Vaitkienė P; Mikučiūnas M; Skauminas K; Tamašauskas A; Kazlauskas A
    J Cancer; 2014; 5(6):446-56. PubMed ID: 24847385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NDRG2, suppressed expression associates with poor prognosis in pancreatic cancer, is hypermethylated in the second promoter in human gastrointestinal cancers.
    Yamamura A; Miura K; Karasawa H; Motoi F; Mizuguchi Y; Saiki Y; Fukushige S; Sunamura M; Shibata C; Unno M; Horii A
    Biochem Biophys Res Commun; 2017 Feb; 484(1):138-143. PubMed ID: 28093228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between MGMT promoter hypermethylation and p53 mutation in glioblastoma.
    Shamsara J; Sharif S; Afsharnezhad S; Lotfi M; Raziee HR; Ghaffarzadegan K; Moradi A; Rahighi S; Behravan J
    Cancer Invest; 2009 Oct; 27(8):825-9. PubMed ID: 19544111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Promoter methylation of AREG, HOXA11, hMLH1, NDRG2, NPTX2 and Tes genes in glioblastoma.
    Skiriutė D; Vaitkienė P; Ašmonienė V; Steponaitis G; Deltuva VP; Tamašauskas A
    J Neurooncol; 2013 Jul; 113(3):441-9. PubMed ID: 23624749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and prognostic value of NDRG2 in human astrocytomas.
    Li L; Wang J; Shen X; Wang L; Li X; Liu Y; Shi M; Zhao G; Deng Y
    J Neurol Sci; 2011 Sep; 308(1-2):77-82. PubMed ID: 21705028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors.
    Möllemann M; Wolter M; Felsberg J; Collins VP; Reifenberger G
    Int J Cancer; 2005 Jan; 113(3):379-85. PubMed ID: 15455350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic inactivation of the RASSF10 candidate tumor suppressor gene is a frequent and an early event in gliomagenesis.
    Hill VK; Underhill-Day N; Krex D; Robel K; Sangan CB; Summersgill HR; Morris M; Gentle D; Chalmers AD; Maher ER; Latif F
    Oncogene; 2011 Feb; 30(8):978-89. PubMed ID: 20956940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients.
    Felsberg J; Rapp M; Loeser S; Fimmers R; Stummer W; Goeppert M; Steiger HJ; Friedensdorf B; Reifenberger G; Sabel MC
    Clin Cancer Res; 2009 Nov; 15(21):6683-93. PubMed ID: 19861461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-transcriptional regulation of O(6)-methylguanine-DNA methyltransferase MGMT in glioblastomas.
    Ramakrishnan V; Kushwaha D; Koay DC; Reddy H; Mao Y; Zhou L; Ng K; Zinn P; Carter B; Chen CC
    Cancer Biomark; 2011-2012; 10(3-4):185-93. PubMed ID: 22674304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of putative tumour suppressor gene GLTSCR2 expression in human glioblastomas.
    Kim YJ; Cho YE; Kim YW; Kim JY; Lee S; Park JH
    J Pathol; 2008 Oct; 216(2):218-24. PubMed ID: 18729076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.